Pharmacovigilance and assessment of drug safety reports during COVID 19
The speed and volume of clinical research to discover effective drug against novel corona virus has been remarkable. To address the unmet medical need, the regulations are made flexible and convenient without any relaxation in drug safety reporting. The pharmacovigilance activities, especially adver...
Main Author: | Mira K Desai |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Perspectives in Clinical Research |
Subjects: | |
Online Access: | http://www.picronline.org/article.asp?issn=2229-3485;year=2020;volume=11;issue=3;spage=128;epage=131;aulast=Desai |
Similar Items
-
SIGNIFICANCE OF PHARMACOVIGILANCE AND ITS CLINICAL IMPLICATIONS
by: Susanta Kumar Bandyopadhyay, et al.
Published: (2016-12-01) -
Pharmacovigilance of cutaneous adverse drug reactions among patients attending dermatology department at a Tertiary Care Hospital
by: Shweta Sharma, et al.
Published: (2019-01-01) -
Big data, medicines safety and pharmacovigilance
by: Rabia Hussain
Published: (2021-06-01) -
Adverse drug reactions monitoring of psychotropic drugs: a tertiary care centre study
by: Hemendra Singh, et al.
Published: (2017-06-01) -
Improved drug safety through intensive pharmacovigilance in hospitalized pediatric patients
by: Alan O. Vázquez-Alvarez, et al.
Published: (2017-12-01)